- Home
- DNTH vs NTB Comparison
DNTH vs NTB Comparison
Compare DNTH & NTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DNTH | NTB |
|---|---|---|
| Founded | 2015 | 1858 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.9B |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | DNTH | NTB |
|---|---|---|
| Price | $44.15 | $46.54 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 3 |
| Target Price | ★ $68.00 | $50.67 |
| AVG Volume (30 Days) | ★ 756.1K | 180.5K |
| Earning Date | 11-05-2025 | 10-28-2025 |
| Dividend Yield | N/A | ★ 4.31% |
| EPS Growth | N/A | ★ 17.07 |
| EPS | N/A | ★ 5.27 |
| Revenue | $3,078,000.00 | ★ $599,452,000.00 |
| Revenue This Year | N/A | $4.46 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.83 |
| Revenue Growth | N/A | ★ 4.60 |
| 52 Week Low | $13.37 | $34.77 |
| 52 Week High | $44.95 | $46.92 |
Technical Indicators
Market Signals| Indicator | DNTH | NTB |
|---|---|---|
| Relative Strength Index (RSI) | 70.70 | 62.29 |
| Support Level | $39.82 | $44.36 |
| Resistance Level | $44.95 | $46.76 |
| Average True Range (ATR) | 2.47 | 0.77 |
| MACD | 0.56 | 0.02 |
| Stochastic Oscillator | 92.31 | 87.30 |
Price Performance
Historical ComparisonAbout DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About NTB Bank of N.T. Butterfield & Son Limited (The) Voting
Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It operates the business through three geographic segments, Bermuda, Cayman Islands, the Channel Islands and the UK. The company offers banking services, comprised of retail and corporate banking, and wealth management, which consists of trust, private banking, and asset management. The company generates a majority of its revenue from Bermuda, and the Cayman Islands segments.